Cogent Biosciences, Inc. Revenue 2017–2020
Cogent Biosciences, Inc. annual/quarterly revenue history and growth rate from 2017 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cogent Biosciences, Inc. revenue for the quarter ending September 30, 2020 was 312000, a 69.41% decrease year-over-year.
- Cogent Biosciences, Inc. revenue for the twelve months ending September 30, 2020 was 8.9 M, a 10.19% decrease year-over-year.
- Cogent Biosciences, Inc. annual revenue for 2020 was 7.9 M, a 65.02% decrease from 2019.
- Cogent Biosciences, Inc. annual revenue for 2019 was 22.5 M, a 131.14% increase from 2018.
- Cogent Biosciences, Inc. annual revenue for 2018 was 9.7 M, a 16.44% increase from 2017.
- Cogent Biosciences, Inc. annual revenue for 2017 was 8.4 M.
Cogent Biosciences, Inc. (COGT) — Frequently Asked Questions
Cogent Biosciences, Inc. (COGT) is a publicly traded US company. It has a market capitalization of $1.02B. In fiscal 2020 it reported revenue of $8M and net income of -$75M. Explore COGT's stock price, financial statements, earnings history, margins and key ratios below.
What is Cogent Biosciences, Inc.'s market cap?
Cogent Biosciences, Inc. (COGT) has a market capitalization of $1.02B.
What is the COGT stock price?
COGT trades at $31.38 (-1.88% on the day).
How much revenue does Cogent Biosciences, Inc. make?
Cogent Biosciences, Inc. reported revenue of $8M in fiscal 2020.
Is COGT profitable?
In fiscal 2020, Cogent Biosciences, Inc. reported net income of -$75M.